Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

3.

Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.

Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M.

Nucl Med Biol. 1999 Jul;26(5):519-27.

PMID:
10473190
4.

Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.

Kessler RM, Votaw JR, de Paulis T, Bingham DR, Ansari MS, Mason NS, Holburn G, Schmidt DE, Votaw DB, Manning RG, et al.

Synapse. 1993 Nov;15(3):169-76.

PMID:
8278895
6.
7.
8.

Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies.

Mathis CA, Bishop JE, Gerdes JM, Whitney JM, Brennan KM, Jagust WJ.

Int J Rad Appl Instrum B. 1992 Jul;19(5):571-88.

PMID:
1399687
9.

Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.

Chumpradit S, Kung MP, Billings J, Mach R, Kung HF.

J Med Chem. 1993 Jan 22;36(2):221-8.

PMID:
8093734
10.
12.

Preparation and preliminary biological evaluation of [18F]NCQ-115: a new selective reversible dopamine D2 receptor ligand.

Najafi A, Peterson A, Buchsbaum M, O'Dell S, Weihmuller F.

Nucl Med Biol. 1993 May;20(4):549-55.

PMID:
8504293
13.

11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain.

Mukherjee J, Shi B, Christian BT, Chattopadhyay S, Narayanan TK.

Bioorg Med Chem. 2004 Jan 2;12(1):95-102.

PMID:
14697774
15.

High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Vandehey NT, Moirano JM, Converse AK, Holden JE, Mukherjee J, Murali D, Nickles RJ, Davidson RJ, Schneider ML, Christian BT.

J Cereb Blood Flow Metab. 2010 May;30(5):994-1007. doi: 10.1038/jcbfm.2009.270. Epub 2009 Dec 30.

16.
17.

Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamides.

Schmidt DE, Votaw JR, Kessler RM, de Paulis T.

J Pharm Sci. 1994 Mar;83(3):305-15.

PMID:
8207673
18.

In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.

Slifstein M, Hwang DR, Huang Y, Guo N, Sudo Y, Narendran R, Talbot P, Laruelle M.

Psychopharmacology (Berl). 2004 Sep;175(3):274-86.

PMID:
15024551
19.

Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging.

Pithia N, Gulati N, Pandey S, Coleman R, Kant R, Mukherjee J.

Nucl Med Biol. 2013 Jul;40(5):697-704. doi: 10.1016/j.nucmedbio.2013.02.011. Epub 2013 Apr 4.

20.

Supplemental Content

Support Center